About this trial
This study aims to evaluate the effect of prognostic factors, such as the severity of pulpal inflammation, carious pulp exposure, and the presence of apical periodontitis, on the success of full pulpotomy in mature permanent molars with irreversible pulpitis. It also aims to investigate the role of artificial intelligence-assisted diagnosis in predicting the prognosis of full pulpotomy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Mature permanent molars with irreversible pulpitis.
Presence of bleeding from all canals.
The tooth is not periodontally compromised.
Disqualifiers
Non-vital teeth.
Uncontrolled bleeding from any of the canals after ten minutes of application of hemostatic agent.
Molars with immature roots.
Trial design
Parallel
Treatments tested in this trial
Conventional root canal treatment
Procedure/SurgeryThe patients will receive conventional root canal treatment, which is the gold standard treatment protocol in cases with irreversible pulpitis.
Full pulpotomy
Procedure/SurgeryThe patients will receive full pulpotomy as follows: -Under rubber dam isolation, the operator will perform caries removal, complete the access cavity preparation, achieve hemostasis in all canals, and apply the bioceramic material. The operator will seal the cavity with a glass ionomer restoration.
Treatment groups
Trial outcomes
Primary outcomes
Percentage of Successful Cases
* It will be measured as a percentage. * It will be decided according to the clinical and radiographic criteria of success and failure.
Diagnostic Accuracy (Sensitivity and Specificity) of an artificial intelligence software in detecting carious pulp exposure
The artificial intelligence (AI) software will process pre-operative radiographs to predict the presence of carious pulp exposure. The AI findings will be compared to the clinical findings of carious pulp exposure after caries removal. (Clinical findings of carious pulp exposure will be used as the gold standard). -The outcome will be reported as sensitivity and specificity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.